Results 1 to 10 of about 175 (118)
Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study [PDF]
The authors wish to make the following corrections to their article: Efimov SV, Matsiyeuskaya NV, Boytsova OV, et al. Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open ...
Sergey V Efimov +10 more
doaj +2 more sources
The Effect of Azoximer Bromide (Polyoxidonium®) in Patients Hospitalized With Coronavirus Disease (COVID-19): An Open-Label, Multicentre, Interventional Clinical Study. [PDF]
Natallia V Matsiyeuskaya +2 more
exaly +2 more sources
Potential of azoximere bromide for treatment of patients with acute inflammatory and infectious upper respiratory diseases [PDF]
Aim. To evaluate the efficacy and safety of Polyoxidonium® in patients with inflammatory and infectious upper respiratory diseases in real clinical practice. Materials and methods.
Valery M. Svistushkin +4 more
doaj +1 more source
. Objective of the work was to conduct a comparative assessment of the immune-modulating effect of the combined use of Yersinia pestis EV NIIEG vaccine strain with Polyoxidonium and Ingaron preparations on a BALB/c mouse model.Materials and methods. Mice
A. Yu. Goncharova +6 more
doaj +1 more source
Background. The study of the reaction of the immune system organs to the introduction of immunomodulators in nematodes is relevant for the development of treatment regimens.
Olga B. Zhdanova +3 more
doaj +1 more source
Application of Polyoxidonium in the Mixed Treatment of Experimental Plague Generalized Forms
Applicability of modern immunomodulator Polyoxidonium for plague treatment was investigated. Inclusion of Polyoxidonium in the therapeutic scheme increased efficiency of treatment with antibiotics of experimental generalized plague in mice challenged ...
T. A. Bondareva +2 more
doaj +1 more source
Aim. Analysis of gynecological diseases structure in which immunocorrection with Polyoxidonium was prescribed, determination of a preferential drug form (suppositories 12 mg/lyophilisate 6 mg), assessment of its clinical effectiveness.
Natalia A. Shchukina +1 more
doaj +1 more source
Immunomodulatory therapy in ENT practice
Area Moscow’s regional research clinical institute n.a. M.F. Vladimirskiy Abstract. The article analyzes the experience of application of the immunomodulator Polyoxidonium in patients with respiratory diseases.
D. M. Mustafaev, V. I. Egorov
doaj +1 more source
The data on the safety and effectiveness of the use of the domestic immunomodulating preparation Polyoxidonium® (azoximer bromide) in children are summarized in the following pages.
V. F. Uchaikin
doaj +1 more source
The article analyses the results of the study of 169 strains of microorganisms obtained from wound discharge from 132 patients with diabetes mellitus. Staphylococcus spp. bacteria held a leading place among Gram-positive pathogens.
V. I. Sokolova +4 more
doaj +1 more source

